Extension of the Cancer Immunotherapy Pilot Program

The Federal Register Vol. 82, Number 120 (Friday, June 23, 2017) published a notice on pages 28645-28646 extending the Cancer Immunotherapy Pilot Program "which permits patent applications pertaining to cancer immunotherapy to be advanced out of turn for examination and reviewed earlier (accorded special status)."

See more at  https://www.gpo.gov/fdsys/pkg/FR-2017-06-23/html/2017-13122.htm

Scam using the name “Patent and Trademark Resource Center, LLC.”

“Patent &Trademark Resource Center, LLC.”

The site — at http://www.ptrc.us/ — mimics the USPTO site, uses a “.us” upper level domain, and is replete with typos.  The same source has also reputedly sent out mailings.

This year another scam using “Patent & Trademark Resource Center” already appears on USPTO’s Non-USPTO Solicitations page.  Please visit this page to learn about this and other scams.

Please be caution your customers that some solicitations call themselves PTRCs.

Please visit the PTRC webpage to learn about the legitimate purposes of PTRCs: https://www.uspto.gov/learning-and-resources/support-centers/patent-and-trademark-resource-centers-ptrcs

If you or one of your customers comes across deceptive solicitations, please also alert USPTO by sending an email to TMFeedback@uspto.gov and include copies of the notice and the envelope it came in.